Episode 173: Biden's drug pricing plan, Wall Street's Alzheimer's fixation, & daily 5 a.m. alarms
b"First, STAT Washington correspondent Nicholas Florko joins us to explain President Biden's proposal to lower drug prices, how it might affect the 2022 election, and why there's still no nominee for FDA commissioner. Then, Shraddha Chakradhar calls in to look back on her time running STAT\\u2019s flagship newsletter, Morning Rounds. We also discuss the rise of Covid-19 mandates, Canada's biotech ambitions, and Wall Street's exuberance over new treatments for Alzheimer's disease."